Search clinical trials for: Hydrochlorothiazide and furosemide

Total 271666 results

Hyogo College of Medicine
Ministry of Health, Labour and Welfare, Japan

Completed

Comparison of Long- and Short-acting Diuretics in Congestive Heart Failure (J-MELODIC)

Congestive Heart Failure

Japan
Hadassah Medical Organization

Recruiting

A Feasibility Non-inferiority Clinical Trial for Dosing of Diuretics in CHF Patients

Congestive Heart Failure

Israel
Fundación para la Investigación del Hospital Clínico...

Completed

Loop Diuretic Dosage in Patients With Acute Heart Failure and Renal Failure: Conventional Versus Carbohydrate Antigen 125-guided Therapy (IMPROVE-HF) (IMPROVE-HF)

Heart Failure

Spain
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Lisinopril and Hydrochlorothiazide Tablets (20+25) mg Under Fed Conditions

Fed

India
University Medical Center Groningen

Not yet recruiting

HYDROchlorothiazide to PROTECT Polycystic Kidney Disease Patients and Improve Their Quality of Life (HYDRO-PROTECT)

ADPKD

Netherlands, United Kingdom, Belgium, Germany, France, Spain
Ranbaxy Laboratories Limited
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Hydrochlorothiazide 50mg Tablets Under Fasting Conditions

Healthy
Medical University of Bialystok

Recruiting

Furosemide Alone or Unexpectedly With Solution of Hypertonic Saline in Nephrotic Syndrome (FLUSH-NS)

Nephrotic Syndrome

Poland
PT. Kimia Farma (Persero) Tbk
PT Pharma Metric Labs

Completed

Bioequivalence Study of Furosemide 40 mg Tablet in 24 Indonesian Healthy Volunteers

Drug Use

Indonesia
Adhish Agarwal
University of Utah Center for Clinical and Translational Science

Completed

Evaluation of Renal Sodium Excretion After Salt Loading in Heart Failure With Preserved Ejection Fraction (ERES-HFpEF)

Heart Failure With Preserved Ejection Fraction

United States
University of Cologne

Completed

Trial on Treatment With Inhaled Furosemide of Preterm and Term Neonates With Transient Tachypnoea

Transient Tachypnoea of the Newborn

Germany
Oxford Brookes University

Unknown

Aerosol Particle Size and Breathing Pattern During Inhaled Furosemide (FurAH-II)

Healthy Volunteers

United Kingdom
Sun Yat-sen University

Withdrawn

Effect of Diuretics on Fluid Status Control and Residual Renal Function in Peritoneal Dialysis Patients

Renal Function Disorder

China
Centro Cardiologico Monzino

Unknown

Induced Diuresis With Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy (CIN) Prevention (MYTHOS)

Contrast Induced Nephropathy

Italy
Assiut University

Not yet recruiting

Natriuresis-Guided Diuretic Therapy in Patients With Acute Heart Failure With Reduced Ejection Fraction and Chronic Kidney Disease

Chronic Kidney Diseases | Acute Heart Failure
Lawson Health Research Institute
University of Western Ontario, Canada

Withdrawn

Bumetanide Versus Furosemide in Heart Failure

Heart Failure

Canada
University of Cincinnati

Terminated

Assessment of Coronary Flow Reserve in Heart Failure Patients After Ultrafiltration Versus Diuretics

Acute Decompensated Heart Failure

United States
University Hospital, Strasbourg, France

Suspended

Specific Blockage of Angiotensine 2 and Podocyturia in Glomerular Nephropathies With Hypertension and Proteinuria

Hypertension | End Stage Renal Disease | Proteinuria

France
Boehringer Ingelheim

Completed

PROBE Parallel 6-week Treatment Comparing Telmisartan/Hydrochlorothiazide (HCT) (40/12.5 or 80/12.5) With Losartan/HCT (50/12.5) Using Ambulatory Blood Pressure Monitoring (ABPM)

Hypertension

United States
University of Sao Paulo

Unknown

Safety and Efficacy of Hydrochlorothiazide in the Treatment of Hypernatremia in Critically Ill Patients (HYDRA)

Critical Illness | Hypernatremia

Brazil
Mode Sensors AS
Oslo University Hospital

Completed

Testing of an Electronic Patch During Mild Dehydration

Dehydration

Norway
Rush University Medical Center

Terminated

Comparison of Diuretic Effect With Furosemide Alone Versus the Combination of Furosemide and Albumin in Cirrhotic Patients

Fluid Overload | Cirrhosis, Liver | Volume Overload

United States
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Lisinopril and Hydrochlorothiazide Tablets (20+25) mg Under Fasting Conditions

Fasting

India
Rabin Medical Center

Completed

Effect of Acetazolamide and Furosemide on Obesity-induced Glomerular Hyperfiltration

Obesity-induced Hyperfiltration

Israel
Children's Hospital Medical Center, Cincinnati
National Heart, Lung, and Blood Institute (NHLBI); Emory University; RTI International and other collaborators

Recruiting

Pragmatic Research on Diuretic Management in Early BPD Pilot (PRIMED)

Bronchopulmonary Dysplasia

United States
Boehringer Ingelheim

Completed

Safety Evaluation of Telmisartan Plus Hydrochlorothiazide in Patients With Mild-to-Moderate Hypertension

Hypertension
Hospital de Clinicas de Porto Alegre

Completed

Effectiveness of a Diuretic Algorithm in Clinical Stability in Heart Failure Patients

Heart Failure

Brazil
University of New Mexico
University of Pittsburgh; Dialysis Clinic, Inc.

Terminated

Epithelial Sodium Channel (ENaC) as a Novel Mechanism for Hypertension and Volume Expansion in Type 2 Diabetes

Hypertension | Proteinuria | Type II Diabetes

United States
Yonsei University

Withdrawn

A Prospective, Single-center, Randomized, Controlled, Open-label, Pilot Study to Compare the Effectiveness and Safety of DIuretics Add-On Strategy in Acute Decompensated Heart Failure Patients (DIOS II)

Congestive Heart Failure
Boehringer Ingelheim

Completed

Telmisartan With or Without Hydrochlorothiazide in Patients With Mild-to-moderate Hypertension

Hypertension
Jiangsu HengRui Medicine Co., Ltd.

Completed

Safety and Effect Study of SHR0532 (Drug Code) Tablets in Patients With Mild Hypertension

Hypertension

China
University of New Mexico

Unknown

A Comparison of Hydrochlorothiazide and Metolazone in Combination With Furosemide in Congestive Heart Failure Patients

Congestive Heart Failure

United States
Bayer

Completed

A Trial to Study BAY1753011 in Patients With Congestive Heart Failure (AVANTI)

Heart Failure (HF)

Spain, Italy, Austria, Bulgaria, Greece, Israel, Poland, Portugal, Hungary
Novartis Pharmaceuticals

Completed

A Study to Investigate the Pharmacodynamic and Pharmacokinetic Interaction Between Aliskiren and Furosemide in Patients With Heart Failure

Heart Failure

Germany, Lithuania
Boehringer Ingelheim

Completed

3 x 3 Factorial Trial of Telmisartan and Hydrochlorothiazide in Patients With Essential Hypertension

Hypertension

Japan
Boehringer Ingelheim

Completed

Telmisartan Plus Hydrochlorothiazide in Subjects With Mild-to-moderate Hypertension Who Failed to Respond to Telmisartan Monotherapy

Hypertension
Boehringer Ingelheim

Completed

Telmisartan Tab Hypertension

Hypertension
Novartis Pharmaceuticals

Terminated

To Study the Effects of Aliskiren on Albuminuria and Various Biomarkers in Patients With Nephropathy (ARIA)

Non-diabetic Nephropathy

Netherlands
University of Kansas Medical Center

Recruiting

Improving Pain Management Via Spinal Cord Stimulation and Blood Pressure Reduction (PASSION)

Hypertension | Chronic Pain | Diuretics Drug Reactions | SCS

United States
Takeda

Completed

Efficacy of Candesartan on Reducing Blood Pressure in Insulin-Resistant, Obese Patients With Hypertension.

Hypertension | Obesity

Germany
Novartis

Completed

Pharmacokinetic Drug Interaction Study Following Co-administration of Valsartan, Hydrochlorothiazide and Amlodipine in Patients With Hypertension

Hypertension

India
Jiangsu HengRui Medicine Co., Ltd.

Completed

Drug-Drug Interaction Study Between Henagliflozin Proline and Hydrochlorothiazide

Diabetes in Adults

China
VA Office of Research and Development

Completed

Diuretic Comparison Project (DCP)

Hypertension

United States, Puerto Rico
Hennepin County Medical Center, Minneapolis
Astellas Pharma Inc

Unknown

Comparing the Effects of Conivaptan and Diuretics on Plasma Neurohormones and Renal Blood Flow in Patients With Chronic Congestive Heart Failure

Heart Failure

United States
Organon and Co

Completed

BP-EASE -Effectiveness of Losartan 50 mg/Hydrochlorothiazide (HCTZ) 12.5 mg Versus Valsartan 80 mg/HCTZ 12.5 mg Titrated as Needed in Patients With Essential Hypertension Not Controlled on Monotherapy (0954A-333) (EASE)

Hypertension
Organon and Co

Completed

Antihypertensive Efficacy and Safety of Approved Drugs in Japanese Patients With Essential Hypertension (Banyu Study)(0954A-302)

Hypertension
University of Cambridge
British Heart Foundation

Unknown

Monotherapy Versus Dual Therapy for Initial Treatment for Hypertension (Pathway 1)

Essential Hypertension | Hypertension, Resistant to Conventional Therapy

United Kingdom
University of Alberta
Alberta Heritage Foundation for Medical Research

Completed

Prevention of Contrast-Induced Nephropathy

Acute Renal Failure | Chronic Renal Failure | Contrast-induced Nephropathy

Canada
Daiichi Sankyo, Inc.
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company

Completed

Combination of Olmesartan and Hydrochlorothiazide in Essential Hypertension

Essential Hypertension

Belgium, Germany, Netherlands, Slovakia
Boehringer Ingelheim

Completed

Randomized, Double-Blind, Placebo-Controlled, Forced-Titration, Comparing Telmisartan vs Valsartan. Taken Orally for Eight Weeks in Patients With Stage 1 and Stage 2 Hypertension

Hypertension

United States
Boehringer Ingelheim

Completed

A Randomized, Double-blind, Parallel-group Assessment of the Safety and Efficacy of Telmisartan 40mg Plus Hydrochlorothiazide 12.5mg (Micardis Plus) in Comparison With Losartan 50mg Plus Hydrochlorothiazide 12.5mg in Taiwanese Patients With Mild to Moderate Hypertension

Hypertension

Taiwan

3

Subscribe